Nisa Investment Advisors
APLS

Nisa Investment Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Nisa Investment Advisors’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-252
Closed -$10.1K – 3101
2026
Q1 		$10.1K Buy
252
+202
+404% +$4.35K ﹤0.01% 2243
2025
Q4 		$1.26K Hold
50
– – ﹤0.01% 2684
2025
Q3 		$1.13K Hold
50
– – ﹤0.01% 2717
2025
Q2 		$866 Hold
50
– – ﹤0.01% 2763
2025
Q1 		$1.09K Hold
50
– – ﹤0.01% 2617
2024
Q4 		$1.6K Sell
50
-16,900
-100% -$508K ﹤0.01% 2560
2024
Q3 		$489K Sell
16,950
-300
-2% -$11.1K ﹤0.01% 1049
2024
Q2 		$662K Sell
17,250
-50,100
-74% -$2.27M ﹤0.01% 992
2024
Q1 		$3.96M Hold
67,350
– – 0.03% 517
2023
Q4 		$4.03M Sell
67,350
-1,000
-1% -$50.7K 0.03% 466
2023
Q3 		$2.6M Buy
68,350
+55,759
+443% +$2.45M 0.02% 592
2023
Q2 		$1.15M Buy
12,591
+2,731
+28% +$236K 0.01% 844
2023
Q1 		$650K Buy
9,860
+12
+0.1% +$692 0.01% 980
2022
Q4 		$509K Sell
9,848
-15
-0.2% -$796 ﹤0.01% 1110
2022
Q3 		$657K Buy
9,863
+563
+6% +$33.3K 0.01% 937
2022
Q2 		$421K Buy
9,300
+7,440
+400% +$339K ﹤0.01% 1114
2022
Q1 		$95K Sell
1,860
-190
-9% -$8.39K ﹤0.01% 1627
2021
Q4 		$83K Sell
2,050
-2,902
-59% -$114K ﹤0.01% 1585
2021
Q3 		$163 Buy
4,952
+2,002
+68% +$112K ﹤0.01% 1487
2021
Q2 		$186 Hold
2,950
– – ﹤0.01% 1436
2021
Q1 		$127 Hold
2,950
– – ﹤0.01% 1649
2020
Q4 		$169K Buy
2,950
+400
+16% +$16.9K ﹤0.01% 1534
2020
Q3 		$77K Buy
2,550
+2,000
+364% +$59.8K ﹤0.01% 1629
2020
Q2 		$18K Hold
550
– – ﹤0.01% 1791
2020
Q1 		$15K Buy
+550
New +$19.5K ﹤0.01% 1766

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nisa Investment Advisors's APLS Position: Q2 2026 in Review

Nisa Investment Advisors sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 252 shares — an estimated $10.1K sold.

Nisa Investment Advisors first reported a position in APLS in Q1 2020 and held it in 25 quarters. The position peaked at $4.03M in Q4 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Nisa Investment Advisors reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Nisa Investment Advisors sold 252 Apellis Pharmaceuticals shares in Q2 2026, an estimated $10.1K.
  • Nisa Investment Advisors first reported a position in Apellis Pharmaceuticals in Q1 2020 and held it in 25 quarters.
  • Nisa Investment Advisors's Apellis Pharmaceuticals position peaked at $4.03M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.